U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Links from MedGen

Items: 1 to 20 of 206

1.
Identification of point mutations in the envelope gene of Moloney murine leukemia virus TB temperature-sensitive paralytogenic mutant ts1: molecular determinants for neurovirulence.
P F Szurek, P H Yuen, R Jerzy, P K Wong
J Virol. 1988 Jan; 62(1): 357–360. doi: 10.1128/jvi.62.1.357-360.1988
PMCID:
PMC250539
SummaryPage BrowsePDF–639K
2.
Mutant ts1 of bacteriophage PM2 is defective in the major capsid protein and fails to package its DNA.
G J Brewer
J Virol. 1983 Jan; 45(1): 226–232. doi: 10.1128/jvi.45.1.226-232.1983
PMCID:
PMC256405
SummaryPage BrowsePDF–1.4M
3.
Hypoxia‐inducible factor‐targeting prodrug TOP3 combined with gemcitabine or TS‐1 improves pancreatic cancer survival in an orthotopic model
Ngoc Thi Hong Hoang, Tetsuya Kadonosono, Takahiro Kuchimaru, Shinae Kizaka‐Kondoh
Cancer Sci. 2016 Aug; 107(8): 1151–1158. Published online 2016 Jul 21. doi: 10.1111/cas.12982
PMCID:
PMC4982586
AbstractArticlePDF–1.6M
4.
Fine Mapping and Candidate Gene Analysis of the Tiller Suppression Gene ts1 in Rice
Lei Liu, Fen Meng, Yonggang He, Menghao Zhu, Yanhao Shen, Zhihong Zhang
PLoS One. 2017; 12(1): e0170574. Published online 2017 Jan 20. doi: 10.1371/journal.pone.0170574
PMCID:
PMC5249193
AbstractArticlePDF–1.4M
5.
ts1, a Paralytogenic mutant of Moloney murine leukemia virus TB, has an enhanced ability to replicate in the central nervous system and primary nerve cell culture.
P K Wong, C Knupp, P H Yuen, M M Soong, J F Zachary, W A Tompkins
J Virol. 1985 Sep; 55(3): 760–767. doi: 10.1128/jvi.55.3.760-767.1985
PMCID:
PMC255060
SummaryPage BrowsePDF–2.8M
6.
Antifungal Activity against Filamentous Fungi of Ts1, a Multifunctional Toxin from Tityus serrulatus Scorpion Venom
Welligton M. Santussi, Karla C. F. Bordon, Ana P. N. Rodrigues Alves, Camila T. Cologna, Suraia Said, Eliane C. Arantes
Front Microbiol. 2017; 8: 984. Published online 2017 Jun 6. doi: 10.3389/fmicb.2017.00984
PMCID:
PMC5459920
AbstractArticlePDF–4.4M
7.
Total Chemical Synthesis of Biologically Active Fluorescent Dye-Labeled Ts1 Toxin
Bobo Dang, Dr. Tomoya Kubota, Prof. Dr. Ana M. Correa, Prof. Dr. Francisco Bezanilla, Prof. Dr Stephen B. H. Kent
Angew Chem Int Ed Engl. Author manuscript; available in PMC 2017 Jun 20.
Published in final edited form as: Angew Chem Int Ed Engl. 2014 Aug 18; 53(34): 8970–8974. Published online 2014 Jul 2. doi: 10.1002/anie.201404438
PMCID:
PMC5477175
AbstractArticlePDF–983K
8.
A 1.6-kilobase-pair fragment in the genome of the ts1 mutant of Moloney murine leukemia virus TB that is associated with temperature sensitivity, nonprocessing of Pr80env, and paralytogenesis.
P H Yuen, D Malehorn, C Knupp, P K Wong
J Virol. 1985 May; 54(2): 364–373. doi: 10.1128/jvi.54.2.364-373.1985
PMCID:
PMC254806
SummaryPage BrowsePDF–1.6M
9.
Molecular cloning of two paralytogenic, temperature-sensitive mutants, ts1 and ts7, and the parental wild-type Moloney murine leukemia virus.
P H Yuen, D Malehorn, C Nau, M M Soong, P K Wong
J Virol. 1985 Apr; 54(1): 178–185. doi: 10.1128/jvi.54.1.178-185.1985
PMCID:
PMC254775
SummaryPage BrowsePDF–1.8M
10.
The neurovirulent determinants of ts1, a paralytogenic mutant of Moloney murine leukemia virus TB, are localized in at least two functionally distinct regions of the genome.
P H Yuen, E Tzeng, C Knupp, P K Wong
J Virol. 1986 Jul; 59(1): 59–65. doi: 10.1128/jvi.59.1.59-65.1986
PMCID:
PMC253038
SummaryPage BrowsePDF–1.4M
11.
Combination TS‐1 plus EGFR‐tyrosine kinase inhibitors (TKIs) for the treatment of non‐small cell lung cancer after progression on first‐line or further EGFR‐TKIs: A phase II, single‐arm trial
Lu Yang, Sheng Yang, Yutao Liu, Junling Li, Xingsheng Hu, Yalei Wang, Yan Zhang, Yan Wang
Thorac Cancer. 2018 Jun; 9(6): 693–698. Published online 2018 Apr 14. doi: 10.1111/1759-7714.12632
PMCID:
PMC5983211
AbstractArticlePDF–166K
12.
Abnormalities in the meibomian glands in patients with oral administration of anticancer combination drug-capsule TS-1®: a case report
Shin Mizoguchi, Yuka Okada, Masahide Kokado, Shizuya Saika
BMC Cancer. 2015; 15: 796. Published online 2015 Oct 24. doi: 10.1186/s12885-015-1781-0
PMCID:
PMC4619999
AbstractArticlePDF–1.3M
13.
The Epoxidation of Limonene over the TS-1 and Ti-SBA-15 Catalysts
Agnieszka Wróblewska
Molecules. 2014 Dec; 19(12): 19907–19922. Published online 2014 Nov 28. doi: 10.3390/molecules191219907
PMCID:
PMC6270933
AbstractArticlePDF–265K
14.
A CsTu‐TS1 regulatory module promotes fruit tubercule formation in cucumber
Sen Yang, Changlong Wen, Bin Liu, Yanling Cai, Shudan Xue, Ezra S. Bartholomew, Mingming Dong, Chen Jian, Shuo Xu, Ting Wang, Wenzhu Qi, Jinan Pang, Dehua Ma, Xingwang Liu, Huazhong Ren
Plant Biotechnol J. 2019 Jan; 17(1): 289–301. Published online 2018 Jul 22. doi: 10.1111/pbi.12977
PMCID:
PMC6330641
AbstractArticlePDF–1.4M
15.
A Val-25-to-Ile substitution in the envelope precursor polyprotein, gPr80env, is responsible for the temperature sensitivity, inefficient processing of gPr80env, and neurovirulence of ts1, a mutant of Moloney murine leukemia virus TB.
P F Szurek, P H Yuen, J K Ball, P K Wong
J Virol. 1990 Feb; 64(2): 467–475. doi: 10.1128/jvi.64.2.467-475.1990
PMCID:
PMC249133
SummaryPage BrowsePDF–2.1M
16.
Efficacy of Paclitaxel plus TS1 against previously treated EGFR mutated non-small cell lung cancer
Yen-Han Tseng, Jen-Fu Shih, Heng-Sheng Chao, Yuh-Min Chen
PeerJ. 2019; 7: e7767. Published online 2019 Sep 24. doi: 10.7717/peerj.7767
PMCID:
PMC6764356
AbstractArticlePDF–324K
17.
Development History and Concept of an Oral Anticancer Agent S-1 (TS-1®): Its Clinical Usefulness and Future Vistas
Tetsuhiko Shirasaka
Jpn J Clin Oncol. 2009 Jan; 39(1): 2–15. Published online 2008 Dec 3. doi: 10.1093/jjco/hyn127
PMCID:
PMC2639406
AbstractArticlePDF–324K
18.
RRM1, ERCC1 and TS1 Immunofluorescence Expression in Leiomyosarcoma: A Tissue Microarray Study with Clinical Outcome Correlation Analysis
Sam D. Zheng, Katherine Bui, Alberto Chiappori, Gerold Bepler, Marilyn M. Bui
Pathol Oncol Res. Author manuscript; available in PMC 2019 Nov 19.
Published in final edited form as: Pathol Oncol Res. 2016 Jul; 22(3): 477–482. Published online 2015 Nov 26. doi: 10.1007/s12253-015-0021-x
PMCID:
PMC6863146
AbstractArticlePDF–688K
19.
TS-1 add-on therapy in Japanese patients with triple-negative breast cancer after neoadjuvant or adjuvant chemotherapy: a feasibility study
Kenichi Inoue, Shigenori E. Nagai, Tsuyoshi Saito, Takashi Sakurai, Kei Kimizuka, Hirofumi Yamada, Toru Kuroda, Satoshi Hata, Yasuo Yamazaki, Masato Kojima, Kazushige Futsuhara, for the SBCCSG-14 investigators
Invest New Drugs. 2020; 38(1): 140–147. Published online 2019 Jul 10. doi: 10.1007/s10637-019-00829-w
PMCID:
PMC6985043
AbstractArticlePDF–536K
20.
Oxidation of Furfural and Furan Derivatives to Maleic Acid in the Presence of a Simple Catalyst System Based on Acetic Acid and TS-1 and Hydrogen Peroxide
Yuzhen Lou, Sinisa Marinkovic, Boris Estrine, Wei Qiang, Gérald Enderlin
ACS Omega. 2020 Feb 18; 5(6): 2561–2568. Published online 2020 Feb 10. doi: 10.1021/acsomega.9b02141
PMCID:
PMC7033676
AbstractArticlePDF–1.6M

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center